The American College of Cardiology and the Association of Black Cardiologists have selected three recipients of the Merck Research Fellowship Award, fostering the next generation of cardiovascular investigators. Awardees will be recognized during the American College of Cardiology's Annual Scientific Session (ACC.25) in Chicago. The ACC/ABC Merck Research Fellowship provides three, one-year fellowships totaling $100,000 to support one [...]

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one rapid-fire abstract and two moderated ePosters on the clinical outcomes and quality of life measures provided by acoramidis in variant transthyretin amyloid cardiomyopathy (ATTR-CM) and one moderated ePoster on a post-hoc analysis of the lower [...]

A recent Northwestern Medicine study published in JAMA has found that one in seven U.S. adults between the ages of 30 and 59 years have a high 30-year risk for cardiovascular disease. The findings emphasize the importance of calculating both short-term and long-term risk for cardiovascular disease in young adults in primary care settings. Read More

The Get a Pulse on PAD campaign — spearheaded by the Society for Cardiovascular Angiography & Interventions (SCAI) and supported by BRG Communications — has been named a finalist in the Association category of the 2025 SABRE Awards North America. This national awareness initiative, developed by the PAD Pulse Alliance — which includes the Association of Black Cardiologists, [...]

What's driving excess cardiovascular mortality in Black Americans? How is financial toxicity impacting care? What's next in amyloid cardiomyopathy treatment and preventive cardiology? In a compelling interview series hosted by NACE Chief Medical Officer Gregg Sherman, M.D., ABC members Drs. Modele Ogunniyi, Selma Mohammed and Eldrin Lewis along with Pam Taub share clinical insights, emerging therapies and strategies [...]